Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001641172-25-005474
Filing Date
2025-04-21
Accepted
2025-04-21 06:04:22
Documents
14

Document Format Files

Seq Description Document Type Size
1 formdefr14a.htm DEFR14A 614620
2 formdef14a_001.jpg GRAPHIC 1461
3 formdef14a_002.jpg GRAPHIC 1599
4 formdef14a_003.jpg GRAPHIC 1479
5 formdef14a_004.jpg GRAPHIC 1083
6 formdef14a_005.jpg GRAPHIC 1075
7 formdef14a_006.jpg GRAPHIC 1069
8 formdef14a_007.jpg GRAPHIC 939
9 formdef14a_008.jpg GRAPHIC 920
10 formdef14a_009.jpg GRAPHIC 5437
11 formdef14a_010.jpg GRAPHIC 4434
12 formdef14a_011.jpg GRAPHIC 1639
13 proxy_001.jpg GRAPHIC 1212067
14 proxy_002.jpg GRAPHIC 691350
  Complete submission text file 0001641172-25-005474.txt   3263777
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-41488 | Film No.: 25851240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)